Chemoinformaics analysis of SALVIA-4(14)-EN-1-ONE
Molecular Weight | 220.356 | nRot | 1 |
Heavy Atom Molecular Weight | 196.164 | nRig | 13 |
Exact Molecular Weight | 220.183 | nRing | 2 |
Solubility: LogS | -3.702 | nHRing | 0 |
Solubility: LogP | 3.39 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 41.855 |
nHD | 0 | BPOL | 24.945 |
QED | 0.611 |
Synth | 3.961 |
Natural Product Likeliness | 2.469 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.003 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.564 |
MDCK | 0.000015 |
BBB | 0.899 |
PPB | 0.867447 |
VDSS | 0.91 |
FU | 0.149077 |
CYP1A2-inh | 0.164 |
CYP1A2-sub | 0.711 |
CYP2c19-inh | 0.139 |
CYP2c19-sub | 0.937 |
CYP2c9-inh | 0.28 |
CYP2c9-sub | 0.756 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.809 |
CYP3a4-inh | 0.114 |
CYP3a4-sub | 0.566 |
CL | 14.676 |
T12 | 0.499 |
hERG | 0.02 |
Ames | 0.024 |
ROA | 0.057 |
SkinSen | 0.044 |
Carcinogencity | 0.667 |
EI | 0.222 |
Respiratory | 0.869 |
NR-Aromatase | 0.008 |
Antiviral | Yes |
Prediction | 0.915838 |